Guardant Health Competitors and Similar CompaniesClear all

Guardant Health's competitors and similar companies include SOPHiA GENETICS, Caris Life Sciences, Castle Biosciences, Biodesix and Tempus AI.

	Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.	SOPHiA GENETICS SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.	Caris Life Sciences Caris Life Sciences is a molecular science company that provides cancer care services.	Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.	Biodesix Biodesix is a company that provides data-driven diagnostic solutions.	Tempus AI Tempus AI (formerly Tempus Labs) is a technology company that develops a data-driven precision medicine platform for the healthcare sector.
Founding Date	Founding Date 2012	Founding Date 2011	Founding Date 2008	Founding Date 2008	Founding Date 2005	Founding Date 2015
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Technology cloud services(SaaS)data automation data management healthtech medical diagnostics platform	Tags Healthcare biotech clinical research oncology	Tags Healthcare biotech medical diagnostics medtech oncology	Tags Healthcare biotech healthtech medical diagnostics platform	Tags Technology artificial intelligence biotech clinical research data management medtech platform
Locations	Locations Redwood City, US HQ	Locations Rolle, CH HQ Bidart, FR Boston, US	Locations Irving, US HQ Tokyo, JP Basel, CH Cambridge, US Irving, US New York, US Phoenix, US see more	Locations Friendswood, US HQ Phoenix, US	Locations Boulder, US HQ De Soto, US	Locations Chicago, US HQ Calgary, CA Barcelona, ES Boston, US Bothell, US Durham, US Lewisburg, US see more
Employees	Employees 1,7681% decrease	Employees 423	Employees 1,468	Employees 61013% increase	Employees 21711% decrease	Employees 2,300
Valuation ($)	Valuation ($) 2.7 b	Valuation ($) 236.4 m	Valuation ($) N/A	Valuation ($) 936.9 m	Valuation ($) 239.5 m	Valuation ($) 7 b
Financial
Revenue (est.)	Revenue (est.) $982m (FY, 2025)	Revenue (est.) $65.2m (FY, 2024)	Revenue (est.) $812m (FY, 2025)	Revenue (est.) $344.2m (FY, 2025)	Revenue (est.) $88.5m (FY, 2025)	Revenue (est.) $1.3b (FY, 2025)
Cost of goods	Cost of goods $349m (FY, 2025)	Cost of goods $17.7m (FY, 2024)	Cost of goods N/A	Cost of goods $71m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $633m (FY, 2025)	Gross profit $47.6m (FY, 2024)	Gross profit N/A	Gross profit $273.2m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($416.3m) (FY, 2025)	Net income ($62.5m) (FY, 2024)	Net income ($68.1m) (FY, 2025)	Net income ($24.2m) (FY, 2025)	Net income ($35.3m) (FY, 2025)	Net income ($245m) (FY, 2025)
Operating ⚠
Facility Space Leased, sq. ft.	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. 42.6 k (FY, 2021)	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. 61.5 k (FY, 2021)	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. N/A
Peer-Reviewed Publications Published	Peer-Reviewed Publications Published N/A	Peer-Reviewed Publications Published 330 (FY, 2021)	Peer-Reviewed Publications Published N/A	Peer-Reviewed Publications Published N/A	Peer-Reviewed Publications Published 275 (Q2, 2020)	Peer-Reviewed Publications Published N/A
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) 9 (FY, 2021)	Trademarks (US) N/A	Trademarks (US) 13 (FY, 2021)	Trademarks (US) N/A	Trademarks (US) N/A
Funding
Total funding raised	Total funding raised $ 550m	Total funding raised $ 245.8m	Total funding raised $ 1.1b	Total funding raised $ 46.5m	Total funding raised $ 98.2m	Total funding raised $ 620m